[4] Liver enzymes (ALT, AST): While GLP-1medications are not known to cause liver injury and are generally safe in people without advanced liver disease, baseline liver tests may be obtained to evaluate overall metabolic health
and (5) monitor your individual tolerance, since nausea typically decreases after the first 48 weeks of therapy
Blood glucose improvements typically emerge within the first few days, whilst significant weight loss and optimal glycaemic control require several weeks to months of consistent treatment
Nevertheless, tirzepatide use seemed to be associated with a higher risk (RR 1.97, 95% CI 1.143.42, p = 0.558) [129]
Ann Pediatr Endocrinol Metab (2017) 22(3):14552
Qualified applicants complete a secure digital consultation that is reviewed by a licensed medical provider